We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Robotic Liquid Handling Systems Enhance Cancer Virus Research Studies

By LabMedica International staff writers
Posted on 01 Aug 2012
Experiments designed to better the understanding of the biology of viral cancers such as Kaposi’s sarcoma-associated herpesvirus (KSHV) are increasingly being carried out on robotic liquid handling platforms.

One such unit – the Tecan (Männedorf, Switzerland) Freedom EVO 150 robotic platform in 384­well format with integrated LightCycler 480 Real-Time PCR – is in place at the University of North Carolina (Chapel Hill, USA) where investigators are intensively studying KSHV.

The Freedom EVO series offers worktables with building-block modularity that ensures precision, reliable liquid handling, and easy-to-use robotics. More...
Each platform can be combined with a wide choice of robotic arms, liquid handling tools, and application options powered by straightforward software that can be programmed to meet the needs of each individual laboratory. Furthermore, the upgradeable Freedom EVO platform can evolve with changing application requirements making the initial investment in the instrument even more worthwhile.

An example of the type of data obtainable with the Freedom EVO system appeared in the June 27, 2012, online edition of the Journal of Virology. Dr. Pauline Chugh, a postdoctoral research assistant at the University of North Carolina said, “We use three main strategies to investigate viral tumorigenesis – viral gene expression, microRNA (miRNA) expression, and viral load testing of clinical samples – based on 96 primer qPCR arrays. Performing the assays manually would be very labor-intensive, and so we use automation to provide the throughput necessary for these studies.”

“The workstation gives us the ability to perform automated analysis of up to 750 gene sequences per sample in just one day, allowing us to, for example, look at the whole miRNA library following infection with the virus,” said Dr. Chugh. “We have also been able to miniaturize many of our protocols, which offer significant cost savings in terms of reagents. Having the ability to multitask has also significantly improved our productivity, allowing us to perform other experiments or analyze data while the instrument is running. Alternatively, we can load 60 individual arrays onto the Freedom EVO and leave the system running overnight. It’s basically generating data while you sleep.”

Related Links:
Tecan
University of North Carolina



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.